| Application no. and date | 08771569.4 (espacenet) (Federated) (European Patent Register), 20080620 | | Patent/reg. no. and date | DK/EP 2178513, 20110330 | | Publication date | 20100428 | | Priority no. and date | US 945694 P, 20070622 | | EP pub. no. and date |
EP 2178513 20100428 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | 11013-3 | | Inventor | NIKFAR, Faranak, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
DIAZ, Steven, 1007 Laurel Trail
Martinsville, New Jersey 08836, US,
KOO, Otilia May Yue, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/551 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , C07D 213/42 (2006.01) | | Title | Sammensætninger i tabletform indeholdende atazanavir | | Int. application no. | US2008067633 | | Int. publication no. | WO2009002829 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
